Grifols S.A. ADR Stock
Grifols S.A. ADR Stock
We can see a decrease in the price for Grifols S.A. ADR. Compared to yesterday it has lost -€0.100 (-1.240%).
Pros and Cons of Grifols S.A. ADR in the next few years
Pros
?
S********** s********
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
Cons
?
M***** P*******
?
C******** o* t** e**********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Grifols S.A. ADR vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Grifols S.A. ADR | -1.240% | 9.524% | 30.894% | -9.040% | -12.973% | -33.261% | -57.240% |
Cellectar BioSciences Inc. | -0.520% | 0.000% | 4.972% | -1.554% | -16.667% | -77.647% | - |
Beximco Pharmaceuticals Ltd. GDR | 2.460% | 0.000% | -39.000% | -41.905% | -44.545% | -77.615% | -39.303% |
SELLAS Life Sciences Group Inc | -1.760% | -6.868% | 1.645% | -20.344% | 14.051% | -87.644% | -81.874% |
Comments
Grifols, S.A. (NASDAQ: GRFS) was downgraded by analysts at Deutsche Bank Aktiengesellschaft from a "hold" rating to a "sell" rating.
Show more
Ratings data for GRFS provided by MarketBeat